Advertisement

Topics

Latest "Identifying Predictors Of Response To Antipsychotics Using A Treatment Algorithm" News Stories

12:56 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Identifying Predictors Of Response To Antipsychotics Using A Treatment Algorithm" found in our extensive news archives from over 250 global news sources.

More Information about Identifying Predictors Of Response To Antipsychotics Using A Treatment Algorithm on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Identifying Predictors Of Response To Antipsychotics Using A Treatment Algorithm for you to read. Along with our medical data and news we also list Identifying Predictors Of Response To Antipsychotics Using A Treatment Algorithm Clinical Trials, which are updated daily. BioPortfolio also has a large database of Identifying Predictors Of Response To Antipsychotics Using A Treatment Algorithm Companies for you to search.

Showing "Identifying Predictors Response Antipsychotics Using Treatment Algorithm" News Articles 1–25 of 21,000+

Tuesday 26th March 2019

Promedior Receives Breakthrough Therapy Designation from FDA for PRM-151 in Idiopathic Pulmonary Fibrosis

LEXINGTON, Mass., March 26, 2019 /PRNewswire/ — Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that PRM-151, a novel investigational anti-fibrotic immunomodulator, has been granted Breakthrough Therapy designation (BTD) by the U.S. Food and Drug Administration (FDA) for Idiopathic Pulmonary Fibrosis (IPF).&...


Avanir Reports Phase 3 Data of Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer’s Dementia

ALISO VIEJO, Calif., March 25, 2019 /PRNewswire/ — Avanir Pharmaceuticals, Inc. announced today the results from the first study of the company’s phase 3 clinical development program investigating the efficacy, safety and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of moderate-to-severe agitation in patients with Alzheimer&...

HER2+ Breast Cancer Paradigm Slated to Expand With Novel Therapies

Melody A. Cobleigh, MD, sheds light on novel treatment approaches for patients with HER2-positive breast cancer that are under investigation as well as strategies that have already been incorporated into practice.


Progress Continues in HR+/HER2- Breast Cancer Paradigm

Kristin J. Richardson, MD, highlights advances made with CDK4/6 inhibitors in the treatment of patients with hormone receptor-positive metastatic breast cancer and forecasts where treatment is headed in this space.

Postpartum depression: new drug will be monitored at approved sites

The first drug approved by the US Food and Drug Administration for the treatment for postpartum depression will be administered only to short term inpatients at specially approved sites, as the FDA...

Elekta Unity MR-linac receives medical device license from Health Canada

“We are pleased to have achieved this important milestone toward making Elekta Unity available in Canada and expect that this important new treatment option will become available to The post Elekta Unity MR-linac receives medical device license from Health Canada appeared first on Compelo Medical Devices - Latest industry news and analysis.

STAT Plus: With an experimental NASH treatment, NGM aims to be the next billion-dollar biotech

NGM Biopharmaceuticals wants to be the next billion-dollar biotech on Wall Street, and so it's moving forward with an IPO that offers a springtime referendum on investor sentiment.

Eisai, Biogen move Alzheimer’s treatment into Phase III

Eisai and Biogen's BAN2401 is to be put into Phase III trial for patients with early Alzheimer's disease.

A New Edition of Maternal and Child Health Journal Is Now Available

Maternal and Child Health Journal (vol. 22, no. 12, 2018) is available online by subscription only. Articles include: “Progress Toward Eliminating Mother to Child Transmission of HIV in Kenya: Review of Treatment Guidelines Uptake and Pediatric Transmission Between 2013 and … Read More

Helping Each New Generation of Parents Tackle the Age-Old Challenge of Head Lice—Safely and Effectively

The National Pediculosis Association Continues its Leadership Role with New Educational Resources and the Tools to CombFirst! NEWTON, Mass. (PRWEB) March 26, 2019 No matter how each new generation of parents differs from its predecessors, one fact remains the same—sooner or later, they will be challenged by a lice infestation first identified at school, a childcare center, or camp. What’s cha...

Fina Biosolutions’ Licensee Successfully Completes a Phase 3 Study and Enters World Health Organization (WHO) Registration for Pneumosil®

Serum Institute of India completes a Phase 3 clinical trial with chemistry developed by Fina Biosolutions Fina Biosolutions is pleased to announce that the Serum Institute of India Private Limited (SIIPL), has completed a Phase 3 study for Pneumosil® a 10-valent pneumococcal conjugate vaccine, in which the Serum Institute indicates all primary and sec...

OncoLens Raises Seed Funding of $1.35 Million Led by BIP Capital and Atlanta Technology Angels

Platform enables a diverse and multispecialty cancer care team to seamlessly collaborate on treatment plans for individual patients. OncoLens, a technology company serving cancer care programs has successfully closed a $1.35 million seed round. BIP Capital and Atlanta Technology Angels (ATA) led the round. The company will deploy the capital toward its...

Medical Device Startup HeartHero Wins Innovation Challenge With Mission to Save Lives Via Personal Automated External Defibrillator (AED)

HeartHero, the medical device startup and creator of the ultra-portable, affordable, and user-friendly automated external defibrillator (AED) was recently awarded a win at the American College of Cardiology’s 68th annual conference, ACC.19. Co-hosted with

Quick Take: Pulsed Dye Laser Treatment of Port-Wine Stains in Infancy Without the Need for General Anesthesia

There is currently controversy surrounding the use of laser treatment for port-wine stains (PWS) in children, with specific concerns around the repetitive use of general anesthesia. Initiating treatment during infancy has been proposed as a way of avoiding the need for general anesthesia, as it is easier to hold the patient still during treatment. In […] Source: 2 Minute Medicine

Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection

– In Clinical Trials, Biktarvy Demonstrated High Efficacy, Few Interactions with Other Drugs and a High Barrier to Resistance Through 48 Weeks – Gilead Sciences, Inc. (NASDAQ:GILD) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, ...

State Highlights: Response To Legionnaires’ Outbreak Faulty At Illinois VA Hospital, Report Finds; N.J. Governor Plans To Sign Aid-In-Dying Bill

Media outlets report on news from Illinois, New Jersey, New York, Arizona, Tennessee, Louisiana, California, Pennsylvania, Texas, Maryland, Ohio, Georgia, Virginia and Washington.

Texas Bill Over ‘Rights Of Living Child After An Abortion’ Provokes Boycott From Democrats

“While some members of the Texas Legislature insist on attacking as well as offending women directly and indirectly, we will not join this charade by participating in this political grandstanding on issues which are already codified in Texas and Federal law,” the Texas lawmakers said. The boycott came in response to legislation that would explicitly require doctors to care for a baby who survi...

InControl Medical Wins FDA Clearance for Attain: The First Over-the-Counter, At-Home Device for the Treatment of Urinary and/or Fecal Incontinence in Women

InControl Medical wins FDA clearance for new Attain, the first over-the-counter (OTC) non-implantable muscle stimulator designed for at-home use to help treat the approximately 60 million women in the U.S. suffering with stress, urge, mixed urinary incontinence and/or bowel incontinence. This is good news for all

SHAPE Doctors Urge People to Consider Coronary Calcium Score Before Stopping Aspirin

Individuals with a calcium score above 100 should think twice about stopping aspirin. The higher the calcium score the more likely aspirin benefit exceeds harm. PALO ALTO, Calif. (PRWEB) March 26, 2019 Leading preventive cardiologists and academic cardiovascular specialists from the Society for Heart Attack Prevention and Eradication (SHAPE), (http://www.shapesociety.org), a non-profit organizati...

Cidara Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Six poster presentations include new analyses from Phase 2 STRIVE clinical trial of rezafungin Four oral presentations include first scientific presentation of new data highlighting the potential of its Cloudbreak antiviral conjugates (AVCs) for influenza Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel...

ReviveMed Receives Frost & Sullivan AI-Driven Next-Generation Metabolomics Technology Innovation Award

ReviveMed is proud to announce that they are the recipient of the North American AI-Driven Next-Generation Metabolomics Technology Innovation Award from Frost & Sullivan as part of that company's 2018 Best Practices Awards. Frost & Sullivan, which has been providing a wide range of business consulting and market research analysis for over 50 years,...

Aphios Granted European Patent for Novel Bryostatin to Treat Alzheimer’s Disease, HIV-1, and Cancers

Aphios Corporation today announced that it has been granted European Patent No. 2 925 315 B1 entitled “Bryoid Compositions, Methods of Making and Use Thereof,” for the composition of matter of a novel Bryostatin, method of manufacturing and for use in the treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Down’s syndrome, H...

Another Major Accomplishment for Dune Medical as it Launches its First In-Man Trial for its Revolutionary Smart Biopsy Device

Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radio-frequency (RF) spectroscopy technology. This press release features multimedia. View the full release here: https://

Tarveda Therapeutics to Present Nonclinical Data on PEN-221 in Combination with Epigenetic Modulation at the 2019 AACR Annual Meeting

- Data demonstrate how an HDAC inhibitor increases the tumor expression of SSTR2 with synergy of efficacy - Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company discovering and developing a new class of potent and selective miniature drug conjugates (Pentarins®) for the treatment of patients with a wide range of solid tumors,

Charles River Laboratories Highlights Commitment to Oncology Research at 2019 AACR Annual Meeting

Researchers will highlight work in BRCA-deficient and rare pediatric cancers Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting, with 19 scientific posters and two oral presentations to highlight its enhanced o...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks